FF301

Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities

For the month ended:

31

January 2022

Status: New Submission

To : Hong Kong Exchanges and Clearing Limited

Name of Issuer:

上海復星醫藥(集團)股份有限公司 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (a joint stock limited company incorporated in the PRC with limited liability)

Date Submitted:

07

February 2022

I. Movements in Authorised / Registered Share Capital

1. Type of shares

Ordinary shares

Class of shares

Class H

Listed on SEHK (Note 1)

Yes

Stock code

02196

Description

Number of authorised/registered shares

Par value

Authorised/registered share capital

Balance at close of preceding month

551,940,500

RMB

1

RMB

551,940,500

Increase / decrease (-)

0

RMB

0

Balance at close of the month

551,940,500

RMB

1

RMB

551,940,500

2. Type of shares

Ordinary shares

Class of shares

Class A

Listed on SEHK (Note 1)

No

Stock code

600196

Description

Number of authorised/registered shares

Par value

Authorised/registered share capital

Balance at close of preceding month

2,010,958,045

RMB

1

RMB

2,010,958,045

Increase / decrease (-)

0

RMB

0

Balance at close of the month

2,010,958,045

RMB

1

RMB

2,010,958,045

Total authorised/registered share capital at the end of the month:

RMB

2,562,898,545

Page 1 of 6

v 1.0.1

FF301

II. Movements in Issued Shares

1. Type of shares

Ordinary shares

Class of shares

Class H

Listed on SEHK (Note 1)

Yes

Stock code

02196

Description

Balance at close of preceding month

551,940,500

Increase / decrease (-)

0

Balance at close of the month

551,940,500

2. Type of shares

Ordinary shares

Class of shares

Class A

Listed on SEHK (Note 1)

No

Stock code

600196

Description

Balance at close of preceding month

2,010,958,045

Increase / decrease (-)

0

Balance at close of the month

2,010,958,045

Page 2 of 6

v 1.0.1

FF301

III. Details of Movements in Issued Shares

(A). Share Options (under Share Option Schemes of the Issuer) Not applicable

(B). Warrants to Issue Shares of the Issuer which are to be Listed Not applicable

(C). Convertibles (i.e. Convertible into Issue Shares of the Issuer which are to be Listed) Not applicable

(D). Any other Agreements or Arrangements to Issue Shares of the Issuer which are to be listed, including Options (other than Share Options Schemes) Not applicable

(E). Other Movements in Issued Share Not applicable

Page 3 of 6

v 1.0.1

FF301

IV. Information about Hong Kong Depositary Receipt (HDR) Not applicable

Page 4 of 6

v 1.0.1

FF301

V. Confirmations

We hereby confirm to the best knowledge, information and belief that, in relation to each of the securities issued by the issuer during the month as set out in Part III and IV which has not been previously disclosed in a return published under Main Board Rule 13.25A / GEM Rule 17.27A, it has been duly authorised by the board of directors of the listed issuer and, insofar as applicable:

(Note 2)

  1. all money due to the listed issuer in respect of the issue of securities has been received by it;
  2. all pre-conditions for listing imposed by the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited under "Qualifications of listing" have been fulfilled;
  3. all (if any) conditions contained in the formal letter granting listing of and permission to deal in the securities have been fulfilled;
  4. all the securities of each class are in all respects identical (Note 3);
  5. all documents required by the Companies (Winding Up and Miscellaneous Provisions) Ordinance to be filed with the Registrar of Companies have been duly filed and that compliance has been made with other legal requirements;
  6. all the definitive documents of title have been delivered/are ready to be delivered/are being prepared and will be delivered in accordance with the terms of issue;
  7. completion has taken place of the purchase by the issuer of all property shown in the listing document to have been purchased or agreed to be purchased by it and the purchase consideration for all such property has been duly satisfied; and
  8. the trust deed/deed poll relating to the debenture, loan stock, notes or bonds has been completed and executed, and particulars thereof, if so required by law, have been filed with the Registrar of Companies.

Submitted by:

Tricor Investor Services Limited

Title:

H Share Registrar

(Director, Secretary or other Duly Authorised Officer)

Notes

  1. SEHK refers to Stock Exchange of Hong Kong.
  2. Items (i) to (viii) are suggested forms of confirmation which may be amended to meet individual cases. Where the issuer has already made the relevant confirmations in a return published under Main Board Rule 13.25A / GEM Rule 17.27A in relation to the securities issued, no further confirmation is required to be made in this return.

Page 5 of 6

v 1.0.1

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. published this content on 07 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 February 2022 09:57:05 UTC.